Mcrae Capital Management Inc Abbott Laboratories Transaction History

Mcrae Capital Management Inc

$486 Million
Q3 2024

A detailed history of Mcrae Capital Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Mcrae Capital Management Inc holds 6,212 shares of ABT stock, worth $737,799. This represents 0.15% of its overall portfolio holdings.

Number of Shares

6,212

Previous 6,212 -0.0%

Holding current value

$737,799

Previous $645,000 9.77%

% of portfolio

0.15%

Previous 0.15%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 17, 2023	SELL	$95.53 - $114.62 $9,553 - $11,462	-100 Reduced 1.58%	6,212 $601,000
Q2 2023 Jul 21, 2023	BUY	$100.78 - $112.29 $20,156 - $22,458	200 Added 3.27%	6,312 $688,000
Q1 2023 Apr 19, 2023	SELL	$96.86 - $114.01 $4,358 - $5,130	-45 Reduced 0.73%	6,112 $618,000
Q2 2022 Jul 20, 2022	BUY	$102.07 - $123.37 $4,593 - $5,551	45 Added 0.74%	6,157 $669,000
Q4 2021 Jan 26, 2022	BUY	$115.53 - $141.46 $11,553 - $14,146	100 Added 1.66%	6,112 $860,000
Q2 2021 Jul 28, 2021	SELL	$105.79 - $124.53 $105,790 - $124,530	-1,000 Reduced 14.26%	6,012 $697,000
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $21,768 - $25,645	-200 Reduced 2.77%	7,012 $840,000
Q2 2020 Jul 23, 2020	SELL	$76.57 - $98.0 $15,313 - $19,600	-200 Reduced 2.7%	7,212 $659,000
Q1 2020 Apr 16, 2020	BUY	$62.82 - $91.86 $12,564 - $18,372	200 Added 2.77%	7,412 $585,000
Q4 2019 Jan 17, 2020	SELL	$78.51 - $87.4 $133,467 - $148,580	-1,700 Reduced 19.08%	7,212 $626,000
Q1 2019 Apr 16, 2019	SELL	$66.22 - $80.06 $2,781 - $3,362	-42 Reduced 0.47%	8,912 $712,000
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $13,420 - $14,367	-250 Reduced 2.72%	8,954 $511,000
Q3 2017 Oct 23, 2017	BUY	$48.06 - $53.64 $442,344 - $493,702	9,204	9,204 $491,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcrae Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcrae Capital Management Inc with notifications on news.

Account

Mcrae Capital Management Inc Abbott Laboratories Transaction History